ATE297217T1 - Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung - Google Patents

Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung

Info

Publication number: ATE297217T1
Authority: AT; Austria
Prior art keywords: transplant rejection; preventing; composition; treating; compositions
Prior art date: 1999-10-27

Application number

AT00972507T

Other languages

English (en)

Inventor

Alexandra Lucas

Grant D Mcfadden

Robert Zhong

Original Assignee

Alexandra Lucas

Grant D Mcfadden

Robert Zhong

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-27

Filing date

2000-10-27

Publication date

2005-06-15

2000-10-27 Application filed by Alexandra Lucas, Grant D Mcfadden, Robert Zhong filed Critical Alexandra Lucas

2005-06-15 Application granted granted Critical

2005-06-15 Publication of ATE297217T1 publication Critical patent/ATE297217T1/de

Links

206010052779 Transplant rejections Diseases 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
229930105110 Cyclosporin A Natural products 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
101710181917 Serine proteinase inhibitor 1 Proteins 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
230000003409 anti-rejection Effects 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000001684 chronic effect Effects 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
229930182912 cyclosporin Natural products 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Transplantation (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Fertilizers (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT00972507T 1999-10-27 2000-10-27 Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung ATE297217T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US16164399P	1999-10-27	1999-10-27
PCT/CA2000/001279 WO2001030379A2 (en)	1999-10-27	2000-10-27	Compositions and methods for preventing and treating transplant rejection

Publications (1)

Publication Number	Publication Date
ATE297217T1 true ATE297217T1 (de)	2005-06-15

Family

ID=22582094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00972507T ATE297217T1 (de)	1999-10-27	2000-10-27	Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung

Country Status (10)

Country	Link
US (2)	US7514405B2 (de)
EP (1)	EP1223971B1 (de)
JP (1)	JP2003512436A (de)
AT (1)	ATE297217T1 (de)
AU (1)	AU1123001A (de)
CA (1)	CA2385312C (de)
DE (1)	DE60020727T2 (de)
ES (1)	ES2243314T3 (de)
PT (1)	PT1223971E (de)
WO (1)	WO2001030379A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE297217T1 (de)	1999-10-27	2005-06-15	Alexandra Lucas	Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
US7419670B2 (en)	2000-09-29	2008-09-02	Viron Therapeutics, Inc.	Method of treating arthritis with SERP-1 and an immunosuppressant
AU2003280252A1 (en) *	2002-11-01	2004-05-25	Alexandra R. Lucas	Viral serpin regulation of inflamation
US7285530B2 (en)	2004-10-21	2007-10-23	Viron Therapeutics, Inc.	Use of SERP-1 as an antiplatelet agent
WO2009142759A1 (en)	2008-05-23	2009-11-26	Argos Therapeutics, Inc.	Novel soluble cd83 polypeptides, formulations and methods of use
CA2773744A1 (en) *	2009-09-16	2011-03-24	Viron Therapeutics Inc.	Methods of treating a patient receiving a cardiac stent implant
CA2943938A1 (en) *	2013-03-29	2014-10-02	The Regents Of The University Of Colorado, A Body Corporate	Compositions and methods for preparing a subject for organ or non-organ implantation
WO2016154041A1 (en) *	2015-03-20	2016-09-29	University Of Florida Research Foundation Incorporated	Serpin reactive center loop peptides and methods of use
US10653760B2 (en)	2015-07-07	2020-05-19	University Of Florida Research Foundation, Incorporated	Compositions and methods for reducing organ rejection by reducing heparan sulfate in donor transplants
CA3042683A1 (en)	2016-11-07	2018-05-11	Coimmune, Inc.	Bispecific antibodies that modulate tlr-4 signaling and uses thereof
WO2019222710A1 (en) *	2018-05-18	2019-11-21	Arizona Board Of Regents On Behalf Of Arizona State University	Methods of wound healing with serp-1 polypeptides

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5206017A (en)	1986-06-03	1993-04-27	Incyte Pharmaceuticals, Inc.	Use of protease nexin-I as an antiinflammatory
DE3829523A1 (de)	1988-08-31	1990-03-01	Behringwerke Ag	Verwendung von plasminogen-aktivator-inhibitor (pai-2) zur immunsuppression
GB9007971D0 (en) *	1990-04-09	1990-06-06	Imutran Ltd	Pharmaceutical formulations
ATE146970T1 (de)	1990-10-16	1997-01-15	John Lezdey	Behandlung von entzündungen
WO1992022320A1 (en)	1991-06-14	1992-12-23	Genentech, Inc.	C1 inhibitor variants and treating inflammatory response with c1 inhibitor
DE4214215A1 (de)	1992-04-30	1993-11-04	Behringwerke Ag	Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
DK0754054T3 (da)	1994-04-08	2002-10-14	Viron Therapeutics Inc	Antirestenosis-protein
US5624946A (en)	1994-07-05	1997-04-29	Williams; James	Use of leflunomide to control and reverse chronic allograft rejection
US5939525A (en)	1995-03-27	1999-08-17	Viron Therapeutics, Inc.	Methods of treating inflammation and compositions therefor
EP0859638A1 (de)	1995-09-11	1998-08-26	The Governors Of The University Of Alberta	Verfahren zur inhibierung der durch zellen vermittelter zerstörung von targetzellen
GB9811854D0 (en)	1998-06-02	1998-07-29	Ciba Geigy Ag	Organic compounds
ES2215277T3 (es)	1998-08-18	2004-10-01	Panacea Biotec Limited	Composicion de ciclosporina que comprende un vehiculo hidrofilo.
US20020006901A1 (en)	1999-02-05	2002-01-17	Aldo T. Iacono	Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
WO2000053793A1 (en)	1999-03-10	2000-09-14	Human Genome Sciences, Inc.	Brain-associated inhibitor of tissue-type plasminogen activator
ATE297217T1 (de)	1999-10-27	2005-06-15	Alexandra Lucas	Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
US6428308B1 (en)	1999-11-29	2002-08-06	Honeywell Inc.	Electronic fuel convertibility selection
AU1943501A (en)	1999-12-02	2001-06-12	Viron Therapeutics, Inc.	Methods of treating inflammation and compositions therefor
US7419670B2 (en)	2000-09-29	2008-09-02	Viron Therapeutics, Inc.	Method of treating arthritis with SERP-1 and an immunosuppressant
AU2003280252A1 (en)	2002-11-01	2004-05-25	Alexandra R. Lucas	Viral serpin regulation of inflamation
US7285530B2 (en)	2004-10-21	2007-10-23	Viron Therapeutics, Inc.	Use of SERP-1 as an antiplatelet agent

2000
- 2000-10-27 AT AT00972507T patent/ATE297217T1/de active
- 2000-10-27 PT PT00972507T patent/PT1223971E/pt unknown
- 2000-10-27 CA CA2385312A patent/CA2385312C/en not_active Expired - Fee Related
- 2000-10-27 WO PCT/CA2000/001279 patent/WO2001030379A2/en not_active Ceased
- 2000-10-27 ES ES00972507T patent/ES2243314T3/es not_active Expired - Lifetime
- 2000-10-27 DE DE60020727T patent/DE60020727T2/de not_active Expired - Lifetime
- 2000-10-27 AU AU11230/01A patent/AU1123001A/en not_active Abandoned
- 2000-10-27 JP JP2001532796A patent/JP2003512436A/ja active Pending
- 2000-10-27 EP EP00972507A patent/EP1223971B1/de not_active Expired - Lifetime
2003
- 2003-03-13 US US10/388,149 patent/US7514405B2/en not_active Expired - Fee Related
2009
- 2009-02-23 US US12/380,063 patent/US7906483B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2003512436A (ja)	2003-04-02
CA2385312A1 (en)	2001-05-03
PT1223971E (pt)	2005-10-31
US20090221472A1 (en)	2009-09-03
EP1223971A2 (de)	2002-07-24
DE60020727D1 (de)	2005-07-14
CA2385312C (en)	2012-02-07
WO2001030379A3 (en)	2001-09-20
US7906483B2 (en)	2011-03-15
WO2001030379A2 (en)	2001-05-03
ES2243314T3 (es)	2005-12-01
US7514405B2 (en)	2009-04-07
AU1123001A (en)	2001-05-08
DE60020727T2 (de)	2006-05-04
EP1223971B1 (de)	2005-06-08
US20030171263A1 (en)	2003-09-11

Legal Events

Date

Code

Title

Description

2006-05-15

UEP

Publication of translation of european patent specification

Ref document number: 1223971

Country of ref document: EP

Publication	Publication Date	Title
ATE482712T1 (de)	2010-10-15	Überstände von mesenchymstammzellen zur vorbeugung und behandlung von immunantworten in transplantationen
ATE257386T1 (de)	2004-01-15	Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE383169T1 (de)	2008-01-15	Komponente und zusammensetzungen zur verabreichung von wirkstoffen
DE69713151D1 (de)	2002-07-11	Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE264692T1 (de)	2004-05-15	Verwendung von no synthase hemmern und fängern von reaktiven sauerstoffsformen zur behandlung von ischämie
EA200001109A1 (ru)	2001-06-25	Новые частицы, композиция на их основе и способ лечения с их применением
AR003410A1 (es)	1998-08-05	Composicion para reducir el crecimiento capilar en mamiferos y metodo para producir dicha composicion
ZA953358B (en)	1996-01-17	New pharmaceutical composition based on taxoids
DE69429450D1 (de)	2002-01-24	Die verwendung von angiotensin iii und seiner analoge für die gewebeheilung
DE60020727D1 (de)	2005-07-14	Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
AU9157901A (en)	2002-04-08	Methods of treating inflammatory and immune reactions and compositions therefor
ATE230609T1 (de)	2003-01-15	Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
ES2055415T3 (es)	1994-08-16	S-adenosil-metionina para el tratamiento de pancreatitis y del inmunorechazo del trasplante de pancreas.
NO2019032I1 (no)	2019-07-23	Treosulfan
DE69902999D1 (de)	2002-10-24	Glucocorticoide zur behandlung von glomerulonephitis
ATE474590T1 (de)	2010-08-15	Kombination von immunsuppressiven substanzen zur behandlung oder vorbeugung von transplantat abstossungen
NZ237739A (en)	1993-09-27	Pharmaceutical composition of a complement inhibitor and an immunosuppressant with cyclosporin a-like activity, and its use
ATE330634T1 (de)	2006-07-15	Nicht-peptidische ccr1 rezeptor-antagonisten in kombination mit cyclosporin a zur behandlung von herztransplantatabstossung
MXPA04005097A (es)	2004-08-19	Composicion y metodo para tratar el rechazo cronico de aloinjertos.
YU8104A (sh)	2006-08-17	Oligopeptidi osteogenog rasta kao stimulatori hematopoeze